Management of Caffeine Toxicity
The management of caffeine toxicity should follow a stepwise approach prioritizing supportive care with benzodiazepines as first-line treatment for agitation and cardiovascular symptoms, followed by targeted interventions for specific complications. 1
Clinical Presentation
Caffeine toxicity presents with a spectrum of symptoms depending on serum levels:
- Mild to moderate toxicity: Tachycardia, hypertension, agitation, tremor, insomnia, diuresis, gastrointestinal distress
- Severe toxicity (serum levels >50 mg/L): Hypotension, cardiac arrhythmias, seizures, hypokalemia, hyponatremia, metabolic acidosis, rhabdomyolysis, respiratory failure
- Life-threatening toxicity (serum levels >100 mg/L): Ventricular fibrillation, circulatory collapse, death 2, 3
Initial Management
Airway, Breathing, Circulation
- Secure airway if decreased consciousness
- Provide supplemental oxygen as needed
- Establish IV access for fluid resuscitation
Decontamination
- Consider activated charcoal if presentation is within 1-2 hours of ingestion
- Do not induce emesis
Benzodiazepines
- First-line treatment for agitation, tachycardia, hypertension, and seizures
- Start with 2 mg IV midazolam (benzodiazepine-naïve patients) followed by 1 mg/h infusion if needed 1
- For breakthrough agitation, administer bolus doses of 1-2× hourly infusion rate every 5 minutes
Cardiovascular Management
Hypotension
- IV fluid resuscitation
- Vasopressors (norepinephrine or epinephrine) for refractory hypotension 4
Arrhythmias
Electrolyte Management
- Aggressive potassium replacement for hypokalemia (critical for preventing and treating arrhythmias) 3
- Monitor and correct sodium, magnesium, and calcium abnormalities
Specific Interventions for Severe Toxicity
Seizure Management
- Benzodiazepines are first-line (IV diazepam or lorazepam)
- Consider barbiturates (pentobarbital) for refractory seizures 2
Hyperthermia Management
- Rapid external cooling is highest priority for life-threatening hyperthermia
- Use evaporative or immersive cooling methods 1
Enhanced Elimination
Monitoring
- Continuous cardiac monitoring
- Frequent vital signs
- Serial electrolyte measurements (especially potassium)
- Consider serum caffeine levels if available (toxic >50 mg/L, potentially lethal >100 mg/L) 2, 6
- Monitor for rhabdomyolysis with CK levels
Special Considerations
- Drug Interactions: Caffeine metabolism occurs via CYP1A2. Medications that inhibit this enzyme (fluvoxamine, certain quinolones, mexiletine) can potentiate caffeine toxicity 7
- Disposition: Patients with significant symptoms require admission for monitoring; asymptomatic patients with potentially toxic ingestions should be observed for at least 6 hours
Common Pitfalls to Avoid
- Failing to recognize caffeine as the toxin (consider in patients with unexplained tachycardia, agitation, and seizures)
- Inadequate potassium replacement (critical for preventing fatal arrhythmias) 3
- Using β-blockers for tachycardia (may worsen hypotension)
- Delaying hemodialysis in severe cases with hemodynamic instability
- Underestimating the potential lethality of caffeine overdose (fatal doses typically exceed 5g but can be lower) 6
In summary, management of caffeine toxicity requires prompt recognition, supportive care with benzodiazepines, aggressive electrolyte management, and consideration of enhanced elimination techniques for severe cases.